Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Total Current Liabilities (2020 - 2025)

Historic Total Current Liabilities for Biofrontera (BFRIW) over the last 6 years, with Q3 2025 value amounting to $12.6 million.

  • Biofrontera's Total Current Liabilities rose 1378.72% to $12.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.6 million, marking a year-over-year increase of 1378.72%. This contributed to the annual value of $12.0 million for FY2024, which is 3354.16% down from last year.
  • According to the latest figures from Q3 2025, Biofrontera's Total Current Liabilities is $12.6 million, which was up 1378.72% from $19.7 million recorded in Q2 2025.
  • Biofrontera's Total Current Liabilities' 5-year high stood at $29.1 million during Q3 2023, with a 5-year trough of $9.3 million in Q2 2024.
  • Its 5-year average for Total Current Liabilities is $15.5 million, with a median of $13.9 million in 2021.
  • In the last 5 years, Biofrontera's Total Current Liabilities surged by 21303.17% in 2021 and then crashed by 6212.06% in 2024.
  • Quarter analysis of 5 years shows Biofrontera's Total Current Liabilities stood at $13.8 million in 2021, then surged by 51.01% to $20.9 million in 2022, then fell by 13.43% to $18.1 million in 2023, then tumbled by 33.54% to $12.0 million in 2024, then rose by 4.43% to $12.6 million in 2025.
  • Its last three reported values are $12.6 million in Q3 2025, $19.7 million for Q2 2025, and $11.0 million during Q1 2025.